MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended September 30, 2023.
“The third quarter was challenging for Sleep Number and the bedding industry as the consumer demand trajectory changed abruptly midway through the quarter,” said Shelly Ibach, Chair, President and CEO, Sleep Number. “In response, we acted quickly to further reduce costs, recalibrate our sales and marketing approach, and amend our credit agreement to provide additional covenant flexibility through the end of 2024. We expect these actions and broad-based restructuring initiatives to result in a more durable operating model with improved profitability and cash flows in a range of economic environments. We remain confident in our strategic direction and ability to deliver superior value creation over time.”
Third Quarter Financial Overview
- Net sales decreased 13% to $473 million; demand decelerated abruptly in August and September, leading to a low double-digit demand decline for the quarter versus prior year
- Gross margin of 57.4% was up 130 bp versus the prior year, primarily benefiting from pricing actions and easing commodity prices
- Operating expenses were reduced by $25 million to $266 million compared with $290 million last year
- Loss per diluted share of $0.10 compared with diluted earnings per share of $0.22 last year
Cash Flows Overview
- Net cash from operating activities of $32 million for the first nine months of the year, compared with $80 million for the same period last year
- Leverage ratio of 4.8x EBITDAR at the end of the third quarter versus covenant maximum of 5.0x
- Adjusted ROIC of 14.9% for the trailing twelve months
Business Restructuring Actions
In light of the demand trajectory change in August, the company initiated additional cost reduction actions which are expected to reduce 2024 operating expenses by approximately $50 million, and also accelerated gross margin initiatives. The operating expense reductions are incremental to the $80 million of operating expense reductions we expect to realize in 2023.
- The cost restructuring actions are broad-based and include a reduction in headcount across all areas of the organization, including in corporate and R&D functions
- We are rationalizing our store portfolio with a planned closure of 40 to 50 stores by the end of 2024, along with slowing the rate of new store openings and remodels, and also reducing our 2024 capital expenditures
- Gross margin improvement actions include value engineering and cost optimization strategies, including driving additional efficiencies through our manufacturing and home delivery network
- The business restructuring actions are expected to result in up to $20 million of one-time restructuring costs, with an estimated $10 million of the costs being recorded in the fourth quarter of this year
Amended Credit Agreement
- The company also amended the financial covenants of the revolving credit facility to provide greater flexibility through 2024, and right-sized the aggregate availability of the credit facility to $685 million
- Prospectively, the company will be utilizing a new definition for net leverage as highlighted on page 9 of this news release; our leverage ratio under the new definition was 3.8x EBITDAR at end of the third quarter
Financial Outlook
The company updated its full-year 2023 diluted EPS outlook to a loss of up to $0.70 per share. The updated EPS outlook includes an estimated $10 million, or $0.35 per share, of restructuring charges to be recorded in the fourth quarter. The 2023 outlook assumes net sales are down low double digits versus the prior year, with approximately 100 basis points of gross margin rate improvement year-over-year. The company anticipates 2023 capital expenditures of approximately $60 million.
Conference Call Information
Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To access the webcast, visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.
About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 23 billion hours of longitudinal sleep data and expertise to research with global institutions.
Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our almost 4,500 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in over 650 stores and online.
To learn more about life-changing, individualized sleep, visit a Sleep Number store near you, our newsroom. and investor relations sites, or SleepNumber.com
Forward-looking Statements
Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s full-year 2023 diluted EPS and future capital expenditures and operating expenses, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; ability to realize expected cost savings and other benefits related to cost restructuring actions and to avoid unexpected adverse effects on the company; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; bank failures or other events affecting financial institutions; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto. Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.
SLEEP NUMBER CORPORATION | ||||||||||||
AND SUBSIDIARIES |
||||||||||||
Consolidated Statements of Operations |
||||||||||||
(unaudited – in thousands, except per share amounts) |
||||||||||||
|
Three Months Ended |
|||||||||||
|
September 30,
|
|
% of
|
|
October 1,
|
|
% of
|
|||||
Net sales |
$ |
472,648 |
|
|
100.0 |
% |
|
$ |
540,566 |
|
100.0 |
% |
Cost of sales |
|
201,537 |
|
|
42.6 |
% |
|
|
237,479 |
|
43.9 |
% |
Gross profit |
|
271,111 |
|
|
57.4 |
% |
|
|
303,087 |
|
56.1 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|||||
Sales and marketing |
|
221,143 |
|
|
46.8 |
% |
|
|
239,656 |
|
44.3 |
% |
General and administrative |
|
31,948 |
|
|
6.8 |
% |
|
|
36,003 |
|
6.7 |
% |
Research and development |
|
12,633 |
|
|
2.7 |
% |
|
|
14,786 |
|
2.7 |
% |
Total operating expenses |
|
265,724 |
|
|
56.2 |
% |
|
|
290,445 |
|
53.7 |
% |
Operating income |
|
5,387 |
|
|
1.1 |
% |
|
|
12,642 |
|
2.3 |
% |
Interest expense, net |
|
10,958 |
|
|
2.3 |
% |
|
|
5,606 |
|
1.0 |
% |
(Loss) Income before income taxes |
|
(5,571 |
) |
|
(1.2 |
%) |
|
|
7,036 |
|
1.3 |
% |
Income tax (benefit) expense |
|
(3,253 |
) |
|
(0.7 |
%) |
|
|
2,003 |
|
0.4 |
% |
Net (loss) income |
$ |
(2,318 |
) |
|
(0.5 |
%) |
|
$ |
5,033 |
|
0.9 |
% |
|
|
|
|
|
|
|
|
|||||
Net (loss) income per share – basic |
$ |
(0.10 |
) |
|
|
|
$ |
0.23 |
|
|
||
|
|
|
|
|
|
|
|
|||||
Net (loss) income per share – diluted |
$ |
(0.10 |
) |
|
|
|
$ |
0.22 |
|
|
||
|
|
|
|
|
|
|
|
|||||
Reconciliation of weighted-average shares outstanding: |
||||||||||||
Basic weighted-average shares outstanding |
|
22,479 |
|
|
|
|
|
22,218 |
|
|
||
Dilutive effect of stock-based awards |
|
— |
|
|
|
|
|
355 |
|
|
||
Diluted weighted-average shares outstanding |
|
22,479 |
|
|
|
|
|
22,573 |
|
|
For the three months ended September 30, 2023, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.
SLEEP NUMBER CORPORATION |
|||||||||||
AND SUBSIDIARIES |
|||||||||||
Consolidated Statements of Operations |
|||||||||||
(unaudited – in thousands, except per share amounts) |
|||||||||||
|
Nine Months Ended |
||||||||||
|
September 30,
|
|
% of Net Sales |
|
October 1,
|
|
% of Net Sales |
||||
Net sales |
$ |
1,457,964 |
|
100.0 |
% |
|
$ |
1,616,769 |
|
100.0 |
% |
Cost of sales |
|
612,343 |
|
42.0 |
% |
|
|
686,439 |
|
42.5 |
% |
Gross profit |
|
845,621 |
|
58.0 |
% |
|
|
930,330 |
|
57.5 |
% |
Operating expenses: |
|
|
|
|
|
|
|
||||
Sales and marketing |
|
649,410 |
|
44.5 |
% |
|
|
700,405 |
|
43.3 |
% |
General and administrative |
|
111,144 |
|
7.6 |
% |
|
|
116,049 |
|
7.2 |
% |
Research and development |
|
42,521 |
|
2.9 |
% |
|
|
46,908 |
|
2.9 |
% |
Total operating expenses |
|
803,075 |
|
55.1 |
% |
|
|
863,362 |
|
53.4 |
% |
Operating income |
|
42,546 |
|
2.9 |
% |
|
|
66,968 |
|
4.1 |
% |
Interest expense, net |
|
30,008 |
|
2.1 |
% |
|
|
11,352 |
|
0.7 |
% |
Income before income taxes |
|
12,538 |
|
0.9 |
% |
|
|
55,616 |
|
3.4 |
% |
Income tax expense |
|
2,637 |
|
0.2 |
% |
|
|
13,576 |
|
0.8 |
% |
Net income |
$ |
9,901 |
|
0.7 |
% |
|
$ |
42,040 |
|
2.6 |
% |
|
|
|
|
|
|
|
|
||||
Net income per share – basic |
$ |
0.44 |
|
|
|
$ |
1.87 |
|
|
||
|
|
|
|
|
|
|
|
||||
Net income per share – diluted |
$ |
0.44 |
|
|
|
$ |
1.83 |
|
|
||
|
|
|
|
|
|
|
|
||||
Reconciliation of weighted-average shares outstanding: |
|||||||||||
Basic weighted-average shares outstanding |
|
22,412 |
|
|
|
|
22,444 |
|
|
||
Dilutive effect of stock-based awards |
|
146 |
|
|
|
|
515 |
|
|
||
Diluted weighted-average shares outstanding |
|
22,558 |
|
|
|
|
22,959 |
|
|
SLEEP NUMBER CORPORATION |
|||||||
AND SUBSIDIARIES |
|||||||
Consolidated Balance Sheets |
|||||||
(unaudited – in thousands, except per share amounts) |
|||||||
subject to reclassification |
|||||||
|
September 30,
|
|
December 31,
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
906 |
|
|
$ |
1,792 |
|
Accounts receivable, net of allowances of $1,408 and $1,267, respectively |
|
18,631 |
|
|
|
26,005 |
|
Inventories |
|
116,224 |
|
|
|
114,034 |
|
Prepaid expenses |
|
21,076 |
|
|
|
16,006 |
|
Other current assets |
|
41,230 |
|
|
|
39,921 |
|
Total current assets |
|
198,067 |
|
|
|
197,758 |
|
Non-current assets: |
|
|
|
||||
Property and equipment, net |
|
190,707 |
|
|
|
200,605 |
|
Operating lease right-of-use assets |
|
401,564 |
|
|
|
397,755 |
|
Goodwill and intangible assets, net |
|
66,690 |
|
|
|
68,065 |
|
Deferred income taxes |
|
21,391 |
|
|
|
7,958 |
|
Other non-current assets |
|
82,616 |
|
|
|
81,795 |
|
Total assets |
$ |
961,035 |
|
|
$ |
953,936 |
|
Liabilities and Shareholders’ Deficit |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Borrowings under revolving credit facility |
$ |
488,000 |
|
|
$ |
459,600 |
|
Accounts payable |
|
168,883 |
|
|
|
176,207 |
|
Customer prepayments |
|
45,902 |
|
|
|
73,181 |
|
Accrued sales returns |
|
23,012 |
|
|
|
25,594 |
|
Compensation and benefits |
|
24,281 |
|
|
|
31,291 |
|
Taxes and withholding |
|
27,198 |
|
|
|
23,622 |
|
Operating lease liabilities |
|
83,143 |
|
|
|
79,533 |
|
Other current liabilities |
|
58,907 |
|
|
|
60,785 |
|
Total current liabilities |
|
919,326 |
|
|
|
929,813 |
|
Non-current liabilities: |
|
|
|
||||
Operating lease liabilities |
|
356,579 |
|
|
|
356,879 |
|
Other non-current liabilities |
|
105,817 |
|
|
|
105,421 |
|
Total non-current liabilities |
|
462,396 |
|
|
|
462,300 |
|
Total liabilities |
|
1,381,722 |
|
|
|
1,392,113 |
|
Shareholders’ deficit: |
|
|
|
||||
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding |
|
— |
|
|
|
— |
|
Common stock, $0.01 par value; 142,500 shares authorized, 22,228 and 22,014 shares issued and outstanding, respectively |
|
222 |
|
|
|
220 |
|
Additional paid-in capital |
|
12,769 |
|
|
|
5,182 |
|
Accumulated deficit |
|
(433,678 |
) |
|
|
(443,579 |
) |
Total shareholders’ deficit |
|
(420,687 |
) |
|
|
(438,177 |
) |
Total liabilities and shareholders’ deficit |
$ |
961,035 |
|
|
$ |
953,936 |
|
SLEEP NUMBER CORPORATION |
|||||||
AND SUBSIDIARIES |
|||||||
Consolidated Statements of Cash Flows |
|||||||
(unaudited – in thousands) |
|||||||
subject to reclassification |
|||||||
|
Nine Months Ended |
||||||
|
September 30,
|
|
October 1,
|
||||
Cash flows from operating activities: |
|
|
|
||||
Net income |
$ |
9,901 |
|
|
$ |
42,040 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
55,196 |
|
|
|
49,342 |
|
Stock-based compensation |
|
10,872 |
|
|
|
8,585 |
|
Net loss on disposals and impairments of assets |
|
464 |
|
|
|
274 |
|
Deferred income taxes |
|
(13,433 |
) |
|
|
(6,955 |
) |
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
|
7,374 |
|
|
|
(1,029 |
) |
Inventories |
|
(2,190 |
) |
|
|
(11,080 |
) |
Income taxes |
|
3,571 |
|
|
|
4,530 |
|
Prepaid expenses and other assets |
|
(5,903 |
) |
|
|
20,082 |
|
Accounts payable |
|
5,199 |
|
|
|
28,889 |
|
Customer prepayments |
|
(27,279 |
) |
|
|
(34,225 |
) |
Accrued compensation and benefits |
|
(6,923 |
) |
|
|
(23,735 |
) |
Other taxes and withholding |
|
5 |
|
|
|
4,744 |
|
Other accruals and liabilities |
|
(5,038 |
) |
|
|
(1,340 |
) |
Net cash provided by operating activities |
|
31,816 |
|
|
|
80,122 |
|
|
|
|
|
||||
Cash flows from investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(48,022 |
) |
|
|
(52,808 |
) |
Proceeds from sales of property and equipment |
|
10 |
|
|
|
49 |
|
Issuance of notes receivable |
|
(1,317 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(49,329 |
) |
|
|
(52,759 |
) |
|
|
|
|
||||
Cash flows from financing activities: |
|
|
|
||||
Net increase in short-term borrowings |
|
20,334 |
|
|
|
34,781 |
|
Repurchases of common stock |
|
(3,711 |
) |
|
|
(64,141 |
) |
Proceeds from issuance of common stock |
|
428 |
|
|
|
998 |
|
Debt issuance costs |
|
(424 |
) |
|
|
(42 |
) |
Net cash provided by (used in) financing activities |
|
16,627 |
|
|
|
(28,404 |
) |
|
|
|
|
||||
Net decrease in cash and cash equivalents |
|
(886 |
) |
|
|
(1,041 |
) |
Cash and cash equivalents, at beginning of period |
|
1,792 |
|
|
|
2,389 |
|
Cash and cash equivalents, at end of period |
$ |
906 |
|
|
$ |
1,348 |
|
SLEEP NUMBER CORPORATION |
|||||||||||||||
AND SUBSIDIARIES |
|||||||||||||||
Supplemental Financial Information |
|||||||||||||||
(unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
September 30,
|
|
October 1,
|
|
September 30,
|
|
October 1,
|
||||||||
Percent of sales: |
|
|
|
|
|
|
|
||||||||
Retail stores |
|
86.6 |
% |
|
|
86.3 |
% |
|
|
87.1 |
% |
|
|
86.7 |
% |
Online, phone, chat and other |
|
13.4 |
% |
|
|
13.7 |
% |
|
|
12.9 |
% |
|
|
13.3 |
% |
Total Company |
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
||||||||
Sales change rates: |
|
|
|
|
|
|
|
||||||||
Retail comparable-store sales |
|
(14 |
%) |
|
|
(21 |
%) |
|
|
(11 |
%) |
|
|
(10 |
%) |
Online, phone and chat |
|
(14 |
%) |
|
|
0 |
% |
|
|
(13 |
%) |
|
|
3 |
% |
Total Retail comparable sales change |
|
(14 |
%) |
|
|
(18 |
%) |
|
|
(11 |
%) |
|
|
(8 |
%) |
Net opened/closed stores and other |
|
1 |
% |
|
|
2 |
% |
|
|
1 |
% |
|
|
3 |
% |
Total Company |
|
(13 |
%) |
|
|
(16 |
%) |
|
|
(10 |
%) |
|
|
(5 |
%) |
|
|
|
|
|
|
|
|
||||||||
Stores open: |
|
|
|
|
|
|
|
||||||||
Beginning of period |
|
672 |
|
|
|
659 |
|
|
|
670 |
|
|
|
648 |
|
Opened |
|
8 |
|
|
|
12 |
|
|
|
27 |
|
|
|
35 |
|
Closed |
|
(2 |
) |
|
|
(9 |
) |
|
|
(19 |
) |
|
|
(21 |
) |
End of period |
|
678 |
|
|
|
662 |
|
|
|
678 |
|
|
|
662 |
|
|
|
|
|
|
|
|
|
||||||||
Other metrics: |
|
|
|
|
|
|
|
||||||||
Average sales per store ($ in 000's) 1 |
$ |
2,952 |
|
|
$ |
3,302 |
|
|
|
|
|
||||
Average sales per square foot 1 |
$ |
963 |
|
|
$ |
1,093 |
|
|
|
|
|
||||
Stores > $2 million net sales 2 |
|
67 |
% |
|
|
77 |
% |
|
|
|
|
||||
Stores > $3 million net sales 2 |
|
27 |
% |
|
|
38 |
% |
|
|
|
|
||||
Average revenue per smart bed unit 3 |
$ |
5,640 |
|
|
$ |
5,083 |
|
|
$ |
5,822 |
|
|
$ |
5,416 |
|
1 Trailing twelve months Total Retail comparable sales per store open at least one year.
2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)
We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
|
Three Months Ended |
|
Trailing Twelve Months Ended |
|||||||||
|
September 30,
|
|
October 1,
|
|
September 30,
|
|
October 1,
|
|||||
Net (loss) income |
$ |
(2,318 |
) |
|
$ |
5,033 |
|
$ |
4,471 |
|
$ |
53,181 |
Income tax (benefit) expense |
|
(3,253 |
) |
|
|
2,003 |
|
|
1,346 |
|
|
15,247 |
Interest expense |
|
10,958 |
|
|
|
5,606 |
|
|
37,641 |
|
|
13,196 |
Depreciation and amortization |
|
18,200 |
|
|
|
17,180 |
|
|
72,338 |
|
|
64,217 |
Stock-based compensation |
|
982 |
|
|
|
542 |
|
|
15,511 |
|
|
12,097 |
Asset impairments |
|
292 |
|
|
|
95 |
|
|
491 |
|
|
338 |
Adjusted EBITDA |
$ |
24,861 |
|
|
$ |
30,459 |
|
$ |
131,798 |
|
$ |
158,276 |
Free Cash Flow |
|||||||||||||
(in thousands) |
|||||||||||||
|
Three Months Ended |
|
Trailing Twelve Months Ended |
||||||||||
|
September 30,
|
|
October 1,
|
|
September 30,
|
|
October 1,
|
||||||
Net cash provided by (used in) by operating activities |
$ |
13,096 |
|
|
$ |
51,431 |
|
$ |
(12,168 |
) |
|
$ |
87,448 |
Subtract: Purchases of property and equipment |
|
18,123 |
|
|
|
16,249 |
|
|
64,668 |
|
|
|
70,338 |
Free cash flow |
$ |
(5,027 |
) |
|
$ |
35,182 |
|
$ |
(76,836 |
) |
|
$ |
17,110 |
Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)
Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the credit facility prior to, and subsequent to, the November 2, 2023 amendment are presented below:
PRIOR TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023
|
Trailing Twelve Months Ended |
||||
|
September 30,
|
|
October 1,
|
||
Borrowings under revolving credit facility |
$ |
488,000 |
|
$ |
406,300 |
Outstanding letters of credit |
|
7,147 |
|
|
5,947 |
Finance lease obligations |
|
338 |
|
|
450 |
Consolidated funded indebtedness |
$ |
495,485 |
|
$ |
412,697 |
Capitalized operating lease obligations 1 |
|
679,224 |
|
|
650,742 |
Total debt including capitalized operating lease obligations (a) |
$ |
1,174,709 |
|
$ |
1,063,439 |
|
|
|
|
||
Adjusted EBITDA (see above) |
$ |
131,798 |
|
$ |
158,276 |
Consolidated rent expense |
|
113,204 |
|
|
108,457 |
Consolidated EBITDAR (b) |
$ |
245,002 |
|
$ |
266,733 |
Net Leverage Ratio under revolving credit facility (a divided by b) |
4.8 to 1.0 |
|
4.0 to 1.0 |
1 A multiple of six times annual rent expense is used as an estimate for capitalizing our operating lease obligations in accordance with our credit facility.
SUBSEQUENT TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023
|
Trailing Twelve Months Ended |
||||
|
September 30,
|
|
October 1,
|
||
Borrowings under revolving credit facility |
$ |
488,000 |
|
$ |
406,300 |
Outstanding letters of credit |
|
7,147 |
|
|
5,947 |
Finance lease obligations |
|
338 |
|
|
450 |
Consolidated funded indebtedness |
$ |
495,485 |
|
$ |
412,697 |
Operating lease liabilities 1 |
|
439,722 |
|
|
427,613 |
Total debt including operating lease liabilities (a) |
$ |
935,207 |
|
$ |
840,310 |
|
|
|
|
||
Adjusted EBITDA (see above) |
$ |
131,798 |
|
$ |
158,276 |
Consolidated rent expense |
|
113,204 |
|
|
108,457 |
Consolidated EBITDAR (b) |
$ |
245,002 |
|
$ |
266,733 |
Net Leverage Ratio under revolving credit facility (a divided by b) |
3.8 to 1.0 |
|
3.2 to 1.0 |
1 Reflects operating lease liabilities included in our financial statements under ASC 842.
Note - Our Net Leverage Ratio under Revolving Credit Facility, EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)
Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:
|
Trailing Twelve Months Ended |
||||||
|
September 30,
|
|
October 1,
|
||||
Adjusted net operating profit after taxes (Adjusted NOPAT) |
|
|
|
||||
Operating income |
$ |
43,458 |
|
|
$ |
81,625 |
|
Add: Operating lease interest 1 |
|
27,497 |
|
|
|
25,419 |
|
Less: Income taxes 2 |
|
(1,168 |
) |
|
|
(24,306 |
) |
Adjusted NOPAT |
$ |
69,787 |
|
|
$ |
82,738 |
|
|
|
|
|
||||
Average adjusted invested capital |
|
|
|
||||
Total deficit |
$ |
(420,687 |
) |
|
$ |
(437,471 |
) |
Add: Long-term debt 3 |
|
488,338 |
|
|
|
406,750 |
|
Add: Operating lease liabilities 4 |
|
439,722 |
|
|
|
427,613 |
|
Total adjusted invested capital at end of period |
$ |
507,373 |
|
|
$ |
396,892 |
|
|
|
|
|
||||
Average adjusted invested capital 5 |
$ |
469,782 |
|
|
$ |
371,674 |
|
|
|
|
|
||||
Adjusted ROIC 6 |
|
14.9 |
% |
|
|
22.3 |
% |
1 |
Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases. |
|
2 |
Reflects annual effective income tax rates, before discrete adjustments, of 1.6% and 22.7% for September 30, 2023 and October 1, 2022, respectively. |
|
3 |
Long-term debt includes existing finance lease liabilities. |
|
4 |
Reflects operating lease liabilities included in our financial statements under ASC 842. |
|
5 |
Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances. |
|
6 |
Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital. |
|
|
|
|
|
Note - the Company's adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842. The prior period has been updated to reflect this calculation. |
|
|
GAAP - generally accepted accounting principles in the U.S. |
|
|